Liminatus Pharma, Inc. (LIMN) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details Liminatus Pharma, Inc. (NASDAQ:LIMN) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 13, 2026. The Healthcare…
Read more
